Search – Page 69 – Indianapolis Business Journal

Home » Search

Articles

Riley Children’s Foundation announces $175 million campaign

November 27, 2018 | John Russell

It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.

Rising fear among Asians leads Eli Lilly to rethink employee groups

November 24, 2018

New employees at Eli Lilly and Co. get a letter encouraging them to join one of the pharmaceutical firm’s affinity groups. There’s one for African Americans, one for Latino employees—and four for Asians.

Eiteljorg’s Jingle Rails has become a multi-generational holiday tradition

November 21, 2018

More than 35,000 people last year came to the downtown museum to see the G-gauge train display.

Editorial: Cigarette-tax hike is an easy call

November 20, 2018

Business and health interests are calling once again for common-sense legislation to help Hoosiers quit.

Lilly installing new labs, offices, manufacturing lines in $90M project

November 19, 2018 | John Russell

The project will give the Indianapolis-based pharmaceutical company upgraded lab space as it pushes to launch more drugs for diabetes, cancer, pain and other ailments.

Eli Lilly considering sale of China assets to raise cash

November 16, 2018

Indianapolis-based Lilly is working with advisers to gauge interest in selling off a selection of older drugs for antibiotics and central nervous system diseases in China.

Novartis nearly doubled its Endocyte bid during drawn-out courtship

November 8, 2018

The escalation in per-share price—which far exceeds that of other recent deals involving Indiana public companies—reflects the unique nature of M&A in the pharmaceutical realm.

Janitor uprising highlights tensions over outsourcing

November 8, 2018

Nearly 650 Indianapolis-area janitors represented by the Service Employees International Union work for just eight firms that clean downtown office buildings.

Lilly raises guidance after topping profit, revenue expectations

November 6, 2018

Lilly’s revenue in the United States rose 11 percent year-over-year, to $3.4 billion, thanks largely to rising sales of diabetes drugs Trulicity and Basgalar, cancer treatment Verzenio and psoriasis medication Taltz.

Top Indiana CEOs drop $650K on PACs, races

November 1, 2018

An IBJ analysis of political giving this election by CEOs of Indiana’s biggest companies found 56 executives donated $650,000 to nearly 92 organizations and candidates seeking federal office.

2018 WOMAN OF INFLUENCE: Christi Shaw

November 1, 2018

Working at Eli Lilly and Co. right out of college, Christi Shaw went on to other major drug companies before returning to head a division that represents about 40 percent of Lilly’s worldwide revenue.

2018 WOMAN OF INFLUENCE: Courtney Roberts

November 1, 2018

Overseeing Eli Lilly and Co.’s philanthropic work in the United States, Kenya and Mexico, Courtney Roberts also leads a pilot program to address barriers to diabetes care in three local neighborhoods.

2018 WOMAN OF INFLUENCE: Danelle Miller

November 1, 2018

A member of Roche’s Global Quality & Regulatory Leadership Team, Danelle Miller built its regulatory policy function from the ground up.

Eli Lilly partner urges investors to look beyond biotech turmoil

November 1, 2018

Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.

Allegion, Heritage among corporations leaping into venture investing

November 1, 2018

A wave of corporations in central Indiana is creating venture capital arms, pushed partly by the desire to join the technological movement.

Police remove dozens of demonstrators in janitors’ protest

October 26, 2018

Nearly 50 demonstrators, including Democratic City-County Council members Zach Adamson and Duke Oliver, were issued written summons Thursday for violating a city ordinance and not complying with police.

Trump focusing on drug prices, high among voters’ concerns

October 25, 2018

President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.

John Lechleiter: Early childhood education is path out of poverty

October 24, 2018

United Way of Central Indiana is our best chance to focus resources on our community’s education, financial stability, health and other needs.

Home tour: English Tudor on the outside, eclectic on the inside

October 24, 2018

Maigen and Jim Rowe have filled their old home with their own family’s history.

Opioid alternative from Lilly, Pfizer shows promise in study

October 24, 2018

The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.

« Previous 1 … 67 68 69 70 71 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Riley Children’s Foundation announces $175 million campaign

Eiteljorg’s Jingle Rails has become a multi-generational holiday tradition

Editorial: Cigarette-tax hike is an easy call

Lilly installing new labs, offices, manufacturing lines in $90M project

Eli Lilly considering sale of China assets to raise cash

Janitor uprising highlights tensions over outsourcing

Top Indiana CEOs drop $650K on PACs, races

2018 WOMAN OF INFLUENCE: Christi Shaw

2018 WOMAN OF INFLUENCE: Courtney Roberts

2018 WOMAN OF INFLUENCE: Danelle Miller

Eli Lilly partner urges investors to look beyond biotech turmoil

Allegion, Heritage among corporations leaping into venture investing

Police remove dozens of demonstrators in janitors’ protest

Trump focusing on drug prices, high among voters’ concerns

John Lechleiter: Early childhood education is path out of poverty

Home tour: English Tudor on the outside, eclectic on the inside

Opioid alternative from Lilly, Pfizer shows promise in study